Drug Shortage Report for BAQSIMI
| Report ID | 256705 |
| Drug Identification Number | 02492415 |
| Brand name | BAQSIMI |
| Common or Proper name | Glucagon Nasal Powder |
| Company Name | AMPHASTAR PHARMACEUTICALS, INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | GLUCAGON |
| Strength(s) | 3MG |
| Dosage form(s) | POWDER |
| Route of administration | NASAL NASAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 3mg glucagon per device |
| ATC code | H04AA |
| ATC description | GLYCOGENOLYTIC HORMONES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2025-05-12 |
| Actual start date | 2025-05-05 |
| Estimated end date | 2025-06-06 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-05-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11570 SIXTH STREET RANCHO CUCAMONGA, CALIFORNIA UNITED STATES 91730 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-05-06 | English | Compare |
| v2 | 2025-05-05 | French | Compare |
| v1 | 2025-05-05 | English | Compare |
Showing 1 to 3 of 3